94 related articles for article (PubMed ID: 12655355)
1. Characterization of the human lactoferrin (HLF) cell line HLFK1, generated in CBA mice.
Kocieba M; Zimecki M; Chodaczek G
Cell Mol Biol Lett; 2003; 8(1):41-8. PubMed ID: 12655355
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.
Zimecki M; Mazurier J; Spik G; Kapp JA
Arch Immunol Ther Exp (Warsz); 1996; 44(1):51-6. PubMed ID: 8874770
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the mode of antigen presentation required for triggering of T cell proliferation by using various azobenzenearsonate-tyrosine derivatives.
Tadakuma T; Yasuda T; Tamura A; Saito S; Tsumita T; Saito K
J Immunol; 1985 Jan; 134(1):122-8. PubMed ID: 3871097
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose.
Zimecki M; Kocieba M; Kruzel M
Immunobiology; 2002 Mar; 205(1):120-31. PubMed ID: 11999341
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities.
Lönnerdal B; Jiang R; Du X
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):606-14. PubMed ID: 21832946
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
Marchetti M; Ammendolia MG; Superti F
Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
[TBL] [Abstract][Full Text] [Related]
8. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
9. Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery.
Yamasaki Y; Ikenaga T; Otsuki T; Nishikawa M; Takakura Y
Vaccine; 2007 Jan; 25(1):85-91. PubMed ID: 16956699
[TBL] [Abstract][Full Text] [Related]
10. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues.
Fischer R; Debbabi H; Blais A; Dubarry M; Rautureau M; Boyaka PN; Tome D
Int Immunopharmacol; 2007 Oct; 7(10):1387-93. PubMed ID: 17673154
[TBL] [Abstract][Full Text] [Related]
11. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
12. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
Zimecki M; Kruzel ML
Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
[TBL] [Abstract][Full Text] [Related]
13. Bovine lactoferrin protects RSC96 Schwann cells from tumor necrosis factor-alpha-induced growth arrest via extracellular-signal-regulated kinase 1/2.
Lin TY; Kuo CD
Neuroscience; 2008 Jan; 151(2):396-402. PubMed ID: 18063485
[TBL] [Abstract][Full Text] [Related]
14. Effect of bovine lactoferrin on a transmissible AIDS-like disease in mice.
Lubashevsky E; Krifucks O; Paz R; Brenner J; Savransky S; Trainin Z; Ungar-Waron H
Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):181-9. PubMed ID: 15001313
[TBL] [Abstract][Full Text] [Related]
15. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
[TBL] [Abstract][Full Text] [Related]
16. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
17. LFA-1 decreases the antigen dose for T cell activation in vivo.
Wang Y; Shibuya K; Yamashita Y; Shirakawa J; Shibata K; Kai H; Yokosuka T; Saito T; Honda S; Tahara-Hanaoka S; Shibuya A
Int Immunol; 2008 Sep; 20(9):1119-27. PubMed ID: 18644832
[TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro.
Pattamatta U; Willcox M; Stapleton F; Cole N; Garrett Q
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1636-43. PubMed ID: 19060270
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin as an Adjuvant for the Generation of Delayed Type Hypersensitivity to Orally Administered Antigen.
Zimecki M; Kruzel ML; Hwang SA; Wilk KM; Actor JK
Ann Clin Lab Sci; 2021 May; 51(3):359-367. PubMed ID: 34162566
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization.
Parameswaran N; Samuvel DJ; Kumar R; Thatai S; Bal V; Rath S; George A
Infect Immun; 2004 Jul; 72(7):3803-11. PubMed ID: 15213121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
